(Q35197123)

7 August 2017

1 reference

title

Reverse cholesterol transport: high-density lipoprotein's magnificent mile (English)

1 reference

7 August 2017

Peter P Toth

1

1 reference

7 August 2017

publication date

1 September 2003

1 reference

Current Atherosclerosis Reports

7 August 2017

published in

1 reference

7 August 2017

volume

5

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

386-393

1 reference

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0010-5

Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0010-5

1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0010-5

Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0010-5

Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-003-0010-5

Influence of CETP gene variation on plasma lipid levels and coronary heart disease: a survey in Taiwan

21 January 2018

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women

1 reference

12 December 2020

Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase

1 reference

12 December 2020

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis

1 reference

12 December 2020

Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density

1 reference

12 December 2020

The effects of altered apolipoprotein A-I structure on plasma HDL concentration

1 reference

12 December 2020

Hepatic lipase: a pro- or anti-atherogenic protein?

1 reference

12 December 2020

Binding and cross-linking studies show that scavenger receptor BI interacts with multiple sites in apolipoprotein A-I and identify the class A amphipathic alpha-helix as a recognition motif

1 reference

12 December 2020

Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1

1 reference

12 December 2020

Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo

1 reference

12 December 2020

Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver

1 reference

12 December 2020

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

1 reference

12 December 2020

HDL regulates the displacement of hepatic lipase from cell surface proteoglycans and the hydrolysis of VLDL triacylglycerol

1 reference

12 December 2020

The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.

1 reference

12 December 2020

Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease

1 reference

12 December 2020

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

1 reference

12 December 2020

Apolipoprotein A-I(Zavalla) (Leu159-->Pro): HDL cholesterol deficiency in a kindred associated with premature coronary artery disease

1 reference

12 December 2020

Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis

1 reference

12 December 2020

Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis

1 reference

12 December 2020

The effects of mutations in helices 4 and 6 of ApoA-I on scavenger receptor class B type I (SR-BI)-mediated cholesterol efflux suggest that formation of a productive complex between reconstituted high density lipoprotein and SR-BI is required for ef

1 reference

12 December 2020

Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels

1 reference

12 December 2020

The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

A Low Prevalence of Coronary Heart Disease among Subjects with Increased High-Density Lipoprotein Cholesterol Levels, Including Those with Plasma Cholesteryl Ester Transfer Protein Deficiency

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice

1 reference

12 December 2020

Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia

1 reference

12 December 2020

ApoA-I(MALLORCA) impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia

1 reference

12 December 2020

Inhibition of arterial thrombus formation by ApoA1 Milano

1 reference

12 December 2020

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

1 reference

12 December 2020

Consequences of cellular cholesterol accumulation: basic concepts and physiological implications

1 reference

12 December 2020

ATP-binding cassette transporter A1 and cholesterol trafficking

1 reference

12 December 2020

High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion

1 reference

12 December 2020

The impact of phospholipid transfer protein (PLTP) on HDL metabolism

1 reference

12 December 2020

Endothelial lipase is a major determinant of HDL level

1 reference

12 December 2020

Increased ABCA1 activity protects against atherosclerosis.

1 reference

12 December 2020

Quantitative trait loci and candidate genes regulating HDL cholesterol: a murine chromosome map.

1 reference

12 December 2020

ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease

1 reference

12 December 2020

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha

1 reference

12 December 2020

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

1 reference

12 December 2020

Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux

1 reference

12 December 2020

Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein

1 reference

12 December 2020

Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems

1 reference

12 December 2020

Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis

1 reference

12 December 2020

Intracellular cholesterol transport

1 reference

12 December 2020

HDL and arteriosclerosis: beyond reverse cholesterol transport

1 reference

12 December 2020

Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management

1 reference

12 December 2020

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial

1 reference

12 December 2020

Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis

1 reference

12 December 2020

A novel TC deletion resulting in Pro(260)-->Stop in the human LCAT gene is associated with a dominant effect on HDL-cholesterol

1 reference

12 December 2020

Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys.

1 reference

12 December 2020

10.1007/S11883-003-0010-5

Identifiers

DOI

1 reference

7 August 2017

1 reference